Tag: personalized medicine
-
Antidepressants: Cardiometabolic Effects Vary by Medication, Study Finds
Overview: Antidepressants and Cardiometabolic Health Antidepressants are a cornerstone in treating mood disorders, but they can influence cardiometabolic health in diverse ways. A recent study published online in The Lancet highlights that different antidepressants are associated with varying physiological effects beyond mood improvement. This has important implications for clinicians and patients who must weigh mental…
-
Antidepressants Vary Significantly in Cardiometabolic Effects: What New Research Means for Patients
Overview: Antidepressants and Metabolic Health Antidepressants are a cornerstone of treatment for depression and anxiety, but they do not affect every patient in the same way. A recent online publication in The Lancet reports that antidepressants can induce cardiometabolic and other physiological changes, and the magnitude and direction of these effects vary across medications. The…
-
Personalized Pain Care Could Transform Life for Australians with Parkinson’s
Overview: The Hidden Burden of Pain in Parkinson’s Parkinson’s disease is widely recognized for tremors and mobility challenges, yet many Australians living with the condition also face persistent pain. Pain can be non-motor in origin, arising from muscle rigidity, postural changes, neuropathic factors, and the tremor-related strain on joints. For some, pain worsens as the…
-
Rochester Regional Health Launches Free GenoWell Genetic Screening Program to Shape Personalized Care
Rochester Regional Health Announces Free GenoWell Genetic Screening Program Rochester Regional Health (RRH) has unveiled GenoWell, a free genetic screening program designed to illuminate how DNA influences participants’ health and guide personalized medical strategies. The initiative, announced in Gates, New York, positions RRH at the forefront of the growing movement toward genomics-informed care and collaborative…
-
Rochester Regional Health Unveils Free GenoWell Genetic Screening Program
Rochester Regional Health has announced the launch of GenoWell, a complimentary genetic screening program and research platform designed to help participants understand how their DNA influences various health outcomes. The initiative, unveiled in Gates, N.Y., marks a notable step forward in personalized medicine, offering participants insights that could inform preventive strategies, lifestyle choices, and potential…
-
GenoWell Genetic Screening Launch by Rochester Regional Health
Rochester Regional Health Introduces GenoWell: A Free Genetic Screening Initiative Gates, N.Y. — Rochester Regional Health is expanding its commitment to preventive care with a new program and research tool called GenoWell. The initiative offers free genetic screening to participants, aiming to illuminate how individual DNA variants influence health outcomes. By combining genetic data with…
-
Personalized TAMENDOX Therapy Boosts Tamoxifen Effectiveness in Early Breast Cancer
Introduction: A new twist in tamoxifen treatment Breast cancer remains the most commonly diagnosed cancer among women worldwide. In a decisive step toward more effective hormone therapy, the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) has unveiled TAMENDOX, a personalized treatment strategy designed to optimize tamoxifen’s impact for individual patients. This multicenter clinical study…
-
Personalized TAMENDOX Therapy Boosts Tamoxifen Effectiveness in Early-Stage Breast Cancer
New Personalized Therapy Aims to Improve Tamoxifen Effectiveness Breast cancer remains the most common cancer among women worldwide, and hormone receptor–positive cancers account for a significant portion of cases. In a notable advance, researchers at the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) have developed a personalized therapy designed to boost the effectiveness of…
-
New Personalized Therapy Boosts Tamoxifen Effectiveness in Breast Cancer Patients
Overview Breast cancer remains the most common cancer among women worldwide. Recent advances from the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) introduce a new personalized therapy, TAMENDOX, designed to tailor hormone treatment to individual patients. The goal is to improve the effectiveness of tamoxifen, a long-standing drug used to treat hormone-dependent breast cancer,…
-
Montreal Chemists Bring Fast DNA-Based Sensor to Drug Monitoring
Breakthrough in DNA-based signaling cascades Researchers at Université de Montréal have announced a groundbreaking approach to monitor drug concentrations in real time using DNA-based signaling cascades. The team, led by chemistry professor Alexis Vallée-Bélisle, has engineered programmable DNA components that report the presence and quantity of various molecules in a drop of blood within five…